Targets 208 genes associated with 37 types of inherited cancers
Heriguard™ comprehensively tests germline genetic alterations to thoroughly reveal hereditary risks in multiple cancer types (see table below). It could be used to screen high-risk populations for different cancer types, guide early diagnosis and prompt intervention before cancer occurs – all of which greatly improve treatment outcomes.
WHO IS IT FOR
Individuals with one or more immediate family member with a single or multiple primary malignant tumors
Individuals with a family history of early onset of tumors, before the age of 50
Individuals with rare malignant tumors, i.e. breast cancer in men
Individuals with precancerous lesions or symptoms, i.e. inflammatory polyps, atypical breast hyperplasia
Individuals who would like to know their hereditary risk of for developing cancer
Hereditary Cancer Types
Bladder cancer
Breast cancer
Cholangiocarcinoma
Colorectal cancer
Endometrial cancer*
Esophageal cancer
Gastric cancer
Intestine cancer
Kidney cancer
Leukemia
Liver cancer
Lung cancer
Ovary cancer*
Testicular cancer#
Thyroid cancer
Pancreatic cancer
Prostate cancer#
*, female only cancers; #, male only cancers.